Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Taurine inhibition of iron-stimulated catecholamine oxidation.

Dawson R Jr, Tang E, Shih D, Hern H, Hu M, Baker D, Eppler B.

Adv Exp Med Biol. 1998;442:155-62. No abstract available.

PMID:
9635027
2.
3.

Cytoprotective role of taurine in a renal epithelial cell culture model.

Eppler B, Dawson R Jr.

Biochem Pharmacol. 2002 Mar 15;63(6):1051-60.

PMID:
11931837
4.

Taurine inhibition of metal-stimulated catecholamine oxidation.

Dawson R Jr, Baker D, Eppler B, Tang E, Shih D, Hern H, Hu M.

Neurotox Res. 2000;2(1):1-15.

PMID:
15545001
5.

Prevention of iron- and copper-mediated DNA damage by catecholamine and amino acid neurotransmitters, L-DOPA, and curcumin: metal binding as a general antioxidant mechanism.

García CR, Angelé-Martínez C, Wilkes JA, Wang HC, Battin EE, Brumaghim JL.

Dalton Trans. 2012 Jun 7;41(21):6458-67. doi: 10.1039/c2dt30060e. Epub 2012 Mar 26.

PMID:
22450660
6.

Effect of L-dopa, oxyferriscorbone and ferrous iron on in vivo lipid peroxidation.

Dostert P, Benedetti MS, Frigerio E.

J Neural Transm Gen Sect. 1991;84(1-2):119-28.

PMID:
2054143
7.

Hypoxic cellular deterioration and its prevention by the amino acid taurine in a transplantation model with renal tubular cells (LLC-PK1).

Wingenfeld P, Minor T, Gehrmann U, Strübind S, Isselhard W, Michalk D.

In Vitro Cell Dev Biol Anim. 1995 Jul-Aug;31(7):483-6. No abstract available.

PMID:
8528493
8.

Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells.

Huang JS, Chuang LY, Guh JY, Yang YL, Hsu MS.

Toxicol Appl Pharmacol. 2008 Dec 1;233(2):220-6. doi: 10.1016/j.taap.2008.09.002. Epub 2008 Sep 12.

PMID:
18834896
9.

Dopamine synthesis and release in LLC-PK1 cells.

Dawson R Jr, Phillips MI.

Eur J Pharmacol. 1990 Dec 15;189(6):423-6.

PMID:
2073931
10.

Antioxidant effect of taurine against lead-induced oxidative stress.

Gürer H, Ozgünes H, Saygin E, Ercal N.

Arch Environ Contam Toxicol. 2001 Nov;41(4):397-402.

PMID:
11598776
11.

Lipid peroxidation stimulated by iron nitrilotriacetate in rat liver.

Goddard JG, Basford D, Sweeney GD.

Biochem Pharmacol. 1986 Jul 15;35(14):2381-7.

PMID:
3729994
12.

Effect of iron and hemoproteins on hydrogen peroxide-supported styrene oxidation to styrene oxide.

Cantoni L, Blezza D, Belvedere G.

Experientia. 1982 Oct 15;38(10):1192-4. No abstract available.

PMID:
6814946
13.
14.

Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.

Hašková P, Kovaříková P, Koubková L, Vávrová A, Macková E, Simůnek T.

Free Radic Biol Med. 2011 Feb 15;50(4):537-49. doi: 10.1016/j.freeradbiomed.2010.12.004. Epub 2010 Dec 13.

PMID:
21147217
15.

[Elemental iron and iron oxides in new applications].

Link A.

Pharm Unserer Zeit. 2009;38(3):231. doi: 10.1002/pauz.200990026. German. No abstract available.

PMID:
19396903
16.

Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation.

Devi SL, Viswanathan P, Anuradha CV.

Eur J Pharmacol. 2010 Nov 25;647(1-3):161-70. doi: 10.1016/j.ejphar.2010.08.011. Epub 2010 Sep 4.

PMID:
20813107
17.

Effect of antioxidants on para-aminophenol-induced toxicity in LLC-PK1 cells.

Hallman MA, Tchao R, Tarloff JB.

Toxicology. 2000 Dec 7;156(1):37-45.

PMID:
11162874
18.

Attenuation of oxidative damage to DNA by taurine and taurine analogs.

Messina SA, Dawson R Jr.

Adv Exp Med Biol. 2000;483:355-67.

PMID:
11787620
19.
20.

Supplemental Content

Support Center